Market Insight Drug Development |

Developing The Next Generation Of Targeted Radionuclide Therapy For The Benefit Of Cancer Patients

Jenny Karlsson

Jenny Karlsson

Senior Director Targeted Radiopharmaceuticals

Bayer

12 August, 2026
Watch time: 20 Minutes

Highlights

Takeaways

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.